Actively Recruiting
Phase III Study Evaluating Magic Ink Tattoos for Radiation Treatment in Women with Breast Cancer
Led by Barbara Ann Karmanos Cancer Institute · Updated on 2025-09-18
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and visibility of a new tattoo ink called Magic Ink compared to standard tattoo ink in women with breast cancer undergoing radiation therapy. The study focuses on whether Magic Ink is as safe as standard ink and if it remains visible for radiation therapists throughout treatment. This research involves women with ductal carcinoma in situ or stage I to III breast cancer preparing for radiation after surgery. Participants will receive a Magic Ink tattoo that is visible only under ultraviolet light, used for radiation guidance during therapy. This ink differs from standard ink by being hidden under normal white light. The study includes skin assessments before and after tattoo application, and during radiation therapy. Surveys about body image and equipment setup ease by medical physicists will also be collected. Throughout the study, participants will have skin evaluations at enrollment, after the first week of radiation, and three months post-treatment. They will complete body image surveys, while medical staff will assess the practicality of using Magic Ink for radiation setup. The main outcome measured is the safety of Magic Ink three months after radiation therapy, along with its effectiveness and impact on body image. The study spans from enrollment through several months of follow-up to monitor these factors.
CONDITIONS
Brief Title
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Research Team
M
Michael Dominello, DO
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here